Preparation of blood products for transfusion: Is there a best method?

Biologicals

Volumn 40, Issue 3, 2012, Pages 187-190

  Devine, Dana V ^a,b   Serrano, Katherine ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apheresis; Blood component; Platelet concentrate; Red blood cells; Transfusion plasma

Indexed keywords

ANALYTIC METHOD; APHERESIS; ARTICLE; BLOOD BUFFY COAT; BLOOD SMEAR; BLOOD TRANSFUSION; HLA MATCHING; HUMAN; PRIORITY JOURNAL; RECIPIENT; RISK BENEFIT ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; THROMBOCYTOPOIESIS;

BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; BLOOD PRESERVATION; COST-BENEFIT ANALYSIS; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 84860616435     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.11.001     Document Type: Article

References (21)

1. Hardwick J. Blood processing. ISBT Sci Ser 2008, 3:148-176.
2. Devine D.V., Howe D. Processing of whole blood into cellular components and plasma. ISBT Sci Ser 2010, 5:78-82.
3. Ness P., Braine H., King K., Barrasso C., Kickler T., Fuller A., et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001, 41:857-861.
4. Andreu G., Vasse J., Sandid I., Tardivel R., Semana G. Use of random versus apheresis platelet concentrates. Transf Clin Biol 2007, 14:514-521.
5. Follea G., Gorham M., Macmillan Douglas A., Clayton R., de Wit H.J.C., Sher G. Developing collaboration between blood establishments, suppliers and regulators: the 'managed convergence'. Vox Sang 2011, 101(Suppl. 1):92.
6. Winters J.L. Complications of donor apheresis. J Clin Apher 2006, 21:132-141.
7. Thomas S., Beard M., Garwood M., Callaert M., van Waeg G., Cardigan R. Blood components produced from whole blood using the Atreus processing system. Transfusion 2008, 48:2515-2524.
8. Sandgren P., Hild M., Sjödin A., Gulliksson H. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability. Vox Sang 2010, 99:341-347.
9. Picker S.M., Radojska S.M., Gathof B.S. In vitro quality of red blood cells (RBCs) collected by multicomponent apheresis compared to manually collected RBCs during 49 days of storage. Transfusion 2007, 47:687-696.
10. Thomas S., Bekoe Y., Uddin S., Beard M., Cardigan R. Double red cell concentrates - in vitro quality after delayed refrigeration. Transfus Med 2010, 20:315-321.
11. Lu F.Q., Kang W., Peng Y., Wang W.M. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method. Transfusion 2011, 10.1111/j.1537-2995.2011.03137.x.
12. van der Meer P.F., Cancelas J.A., Cardigan R., Devine D.V., Gulliksson H., Sparrow R.L., et al. Evaluation of overnight hold of whole blood at room temperature before component processing: effect of red blood cell (RBC) additive solutions on in vitro RBC measures. Transfusion 2011, 51:15S-24S.
13. Schrezenmeier H., Seifried E. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?. Vox Sang 2010, 99:1-15.
14. Jenkins C., Ramírez-Arcos S., Goldman M., Devine D.V. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011 May 26, 10.1111/j.1537-2995.2011.03187.x.
15. Arnold D.M., Heddle N.M., Kulczycky M., Carruthers J., Sigouin C., Blajchman M.A. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy adults. Transfusion 2006, 46:257-264.
16. Vassallo R.R., Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol 2006, 13:323-330.
17. Schubert P., Culibrk B., Coupland D., Scammell K., Gyongyossy-Issa M., Devine D.V. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage. Transfusion 2011 Aug 9, 10.1111/j.1537-2995.2011.03287.x.
18. Serrano K., Scammell K., Weiss S., Culibrk B., Levin E., Gyöngyössy-Issa M., et al. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards. Transfusion 2010, 50:344-353.
19. Cardigan R., van der Meer P.F., Pergande C., Cookson P., Baumann-Paretti B., Cancelas J.A., et al. Coagulation factor content of plasma products from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study. Transfusion 2011, 51:50S-57S.
20. Garner S.F., Jones C.I., Stephens J., Burns P., Walton J., Bernard A., et al. Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality. Transfusion 2008, 48:673-680.
21. Report of the US Department of Health and Human Services The 2009 national blood collection and utilization survey report 2011, US Department of Health and Human Services, Office of the Assistant Secretary for Health, Washington, DC.